Navigating the road ahead: addressing challenges for use of metabolomics in epidemiology studies.

Author(s): Haznadar M,  Maruvada P,  Mette E,  Milner J,  Moore SC,  Nicastro HL,  Sampson JN,  Su LJ,  Verma M,  Zanetti KA

Journal: Metabolomics

Date: 2014 Apr 1

Major Program(s) or Research Group(s): CPFP, NSRG

PubMed ID: 25914611

PMC ID: PMC4407369

Abstract: Metabolomics platforms allow for the measurement of hundreds to thousands of unique small chemical entities, as well as offer extensive coverage of metabolic markers related to obesity, diet, smoking, and other exposures of high interest to health scientists. Nevertheless, its potential use as a tool in population-based study design has not been fully explored. As the field of metabolomics continues to mature, and in part, accelerate through the National Institutes of Health (NIH) investment of ≤65 million in the Common Fund's Metabolomics Program (https://common, it is time to consider those challenges most pertinent to epidemiologic studies.